The M2 protein of influenza A virus is a membrane-spanning tetrameric proton channel targeted by the antiviral drugs amantadine and rimantadine 1 . Resistance to these drugs has compromised their effectiveness against many influenza strains, including pandemic H1N1. A recent crystal structure of M2(22-46) showed electron densities attributed to a single amantadine in the amino-terminal half of the pore 2 , indicating a physical occlusion mechanism for inhibition. However, a solution NMR structure of M2(18-60) showed four rimantadines bound to the carboxy-terminal lipidfacing surface of the helices 3 , suggesting an allosteric mechanism. Here we show by solid-state NMR spectroscopy that two amantadine-binding sites exist in M2 in phospholipid bilayers. The highaffinity site, occupied by a single amantadine, is located in the N-terminal channel lumen, surrounded by residues mutated in amantadine-resistant viruses. Quantification of the protein-amantadine distances resulted in a 0.3 Å -resolution structure of the highaffinity binding site. The second, low-affinity, site was observed on the C-terminal protein surface, but only when the drug reaches high concentrations in the bilayer. The orientation and dynamics of the drug are distinct in the two sites, as shown by 2 H NMR. These results indicate that amantadine physically occludes the M2 channel, thus paving the way for developing new antiviral drugs against influenza viruses. The study demonstrates the ability of solid-state NMR to elucidate small-molecule interactions with membrane proteins and determine high-resolution structures of their complexes.
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The M2 protein of influenza A viruses is a modular, multifunctional protein that plays important roles in the acidification and uncoating of the endosome-entrapped virus and in viral assembly and budding 1, 4 . Its proton-conducting activity is mediated by a single transmembrane (TM) domain that forms a four-helix bundle, which acts as a pH-activated proton channel. The TM domain alone is sufficient for tetramerization 5, 6 and for amantadine-sensitive proton conductivity in vesicles and cell membranes 7, 8 .
The recent low pH crystal structure of micelle-solubilized M2(22-46) shows a single molecule of amantadine (Amt) in the N-terminal pore lumen, consistent with the known stoichiometry of binding 8 and the location of resistant mutations, including Leu 26, Val 27, Ala 30, Ser 31 and Gly 34 (refs 9-11). However, the low-pH state of the protein is only transiently populated in acidifying endosomes, whereas the drug first binds with higher affinity to the protein near neutral pH 9 . Thus, determining the structure of the drug-complexed M2 protein at neutral pH is important for understanding its mechanism of inhibition. The solution NMR structure of micelle-solubilized M2(18-60) at pH 7.5 failed to show strong nuclear Overhauser effects (NOEs) between the drug and pore-lining residues, but it would have been difficult to observe NOEs between the fast-relaxing pore-lining residues and unlabelled rimantadine undergoing restricted motion in the pore. Weak NOEs were observed between residues on the protein surface and the drug which, however, comprised 13% of the detergent in which the protein was dissolved (200-fold excess over protein tetramers). We thus turned to solid-state NMR (SSNMR), which allows for investigation of the dynamics and contacts of drug molecules bound at variable concentrations to membrane proteins in phospholipid bilayers, which are far better mimics of biological membranes than micelles.
Rotational-echo double-resonance (REDOR) NMR is a powerful method to measure sub-nanometre inter-atomic distances with up to 0.1-Å accuracy 12 . The M2 peptide (residues 22-46), reconstituted into DMPC (dimyristoylphosphatidylcholine) vesicles at pH 7.5 under fully tetrameric conditions 6, 13 , contained uniformly 13 C-labelled residues whose 13 C chemical shifts were assigned from two-dimensional correlation spectra ( Supplementary Fig. 1 ). Amantadine was perdeuterated, thus enabling 13 C{ 2 H} REDOR distance measurements (observed nucleus{unobserved nucleus}).
To select for the highest-affinity binding site, we first measured the REDOR spectra of Amt-complexed M2 at an Amt/peptide molar ratio (Amt/P) of 1:4 (one drug per tetramer). At this stoichiometric concentration, Amt binds only to the luminal site: Fig. 1a shows 13 C{ 2 H} REDOR spectra without (S 0 ) and with (S) multiple 2 H dephasing pulses 14 . The Ser 31 Ca signal is strongly dephased by the deuterons (S/S 0 5 0.76 6 0.03 at 10.1 ms), indicating that Amt binds near Ser 31. In contrast, the Asp 44 Ca signal in the peripheral site is unaffected. A double-quantum-filtered REDOR experiment that removed all lipid signals confirmed the lack of Asp 44 dephasing ( Supplementary Fig. 2 ).
To search for additional, lower-affinity, binding sites, we increased the Amt concentration to Amt/P 5 4:4, making the drug 7% of the amphiphiles composing the bilayer, which approaches the large excess of drug in the solution NMR experiments. Now the Asp 44 Ca signal is also dephased (S/S 0 5 0.86 6 0.02 at 10.1 ms), but to a lesser extent than Ser 31 Ca (Fig. 1b ). Thus, when free amantadine is a major component of the membrane, Amt contacts the carboxy terminus of the protein as in the solution NMR structure 3 , but without displacing the drug in the luminal site. Consistently, Amt deuterons also dephased other residues in the luminal site, particularly Val 27 Cc1 and Gly 34 Ca (Fig. 1c, d) , but more weakly than Ser 31. This Ser 31-proximal binding is consistent with the large chemical shift perturbation of Ser 31 by Amt 15 . 2 H NMR provided exquisite details on the orientation and dynamics of amantadine, whose unique symmetry and rigidity simplify analysis. Amantadine is a rigid amphiphile with a polar amine and a hydrophobic adamantane centred around a threefold axis, Z M . Three axial C-D bonds are parallel to Z M while twelve equatorial C-D bonds are at 70u or 110u (h PM ) from Z M (Fig. 2d ). Amantadine partitions strongly into protein-free DMPC vesicles and exhibit 2 H quadrupolar splittings of 36 and 123 kHz with a 4:1 intensity ratio at 243 K ( Fig. 2a ). These splittings indicate fast anisotropic rotation of the molecule around Z M , which scales the couplings from the rigidlimit value of 125 kHz by (3 cos 2 h PM {1)=2, giving 40 kHz for the twelve equatorial bonds and 125 kHz for the three axial bonds. Wobbling of the Z M axis by ,6u probably accounts for the additional motional averaging. As the temperature increased to 303 K, the couplings decreased twofold (18 and 58 kHz) while maintaining the same 1:3 frequency ratio and 4:1 intensity ratio. The 6 0.46 scaling factor indicates Amt rotates rapidly around the normal (ñ n) of the liquidcrystalline bilayer in addition to its own axis, with Z M tilted by 37u or 80u fromñ n ( Fig. 2e) 16 .
When a stoichiometric amount (Amt/P 5 1:4) of protein is present, the Amt spectrum at 243 K resembles the lipid-only spectrum, but the couplings remain unchanged from 243 to 303 K across the membrane phase transition (Fig. 2b) , indicating sequestration of the drug from the lipids. The constant scaling factor (0.93) compared to pure rotation around Z M indicates that the first equivalent of Amt rotates rapidly aroundñ n in a slightly tilted orientation (,13u) between Z M andñ n ( Fig. 2d ). An isotropic peak grows at high temperature, indicating a small fraction (,12% at 303 K) of Amt either near 54.7u from the membrane normal or undergoing large-angle tumbling in the channel. Finally, a weak 18-kHz splitting is observed at 303 K that matches the lipid-only coupling at this temperature. The spectrum is consistent with a 9:1 combination of the 283 K M2-bound spectrum without the 18-kHz splitting and the 303 K lipid-bound spectrum, indicating that 10% of the drug partitions into the bilayer at 303 K.
To confirm that the lumen-bound drug persists under drug excess and to probe for additional binding sites, we measured the 2 H spectra under fourfold excess Amt over the tetramer (corresponding to 12% of the lipid concentration). Figure 2c shows that the spectroscopic signatures of the lumen-bound drug persists, but the 303 K spectrum is now the 1:3 combination of the stoichiometric spectrum ( Fig. 2b ) and the lipid-bound spectrum (Fig. 2a ). No additional bound species was detected. Since the fourfold symmetry of the channel requires four peripheral sites for each luminal site, the 9:1 intensity ratio of the 303 K stoichiometric spectrum indicates that Amt has at least a 40-fold greater affinity for the channel lumen than the peripheral site. These 2 H NMR and distance data indicate that M2 has a single high-affinity site for amantadine, located in the channel lumen centred at Ser 31. In this site, Amt is nearly aligned with the channel axis, but given sufficient thermal energy a small fraction of drug is also able to undergo nearly isotropic motion, as suggested by molecular dynamics simulations 17, 18 . Excess Amt adopts a significantly tilted orientation in the membrane, with or without the protein. The peripherally bound rimantadines in the solution NMR structure are tilted by 80u (ref.
3), precisely one of the two possible orientations found for the lipid-associated drug. Since the same peripheral site is detected here in the TM peptide, its existence is independent of the protein length or the membrane environment; it is the result of excess drugs in the micelles and lipid bilayers.
To determine the sub-angstrom resolution structure of the highaffinity binding site, we quantified the M2-Amt distances using an alternative REDOR experiment containing multiple 13 C pulses and one 2 H pulse, thus minimizing 2 H pulse imperfections and yielding REDOR intensities closely following the universal curve 19 (Supplementary Fig. 3 ). The experiment yielded significantly faster REDOR dephasing (Fig. 3) while confirming the relative dephasing of different sites in Fig. 1 .
Due to the fourfold symmetry of the tetramer, we parameterized the REDOR simulations in terms of the distance R of each peptide carbon from the channel axis and the distance Z of each carbon plane from the Amt centre (Fig. 3c) . We considered the twelve deuterons in the two equatorial planes with rotational averaging and neglected the three axial deuterons due to poor inversion of their broad 2 H spectra. A series of REDOR curves were calculated for R of 2.7-6.2 Å and various Z values for each R, capturing the geometry of previous M2 structural models, (Fig. 3d-f ). The curves are quite sensitive to geometry. The Ser 31 Ca pore radius is most tightly constrained, to 5.7-6.3 Å . Larger R would not give sufficient dephasing even when Z 5 0, whereas smaller R would shift the drug up or down the channel too much to comply with the observed intensities of Val 27 Cc1 and Gly 34 Ca. The best-fit Z places Ser 31 Ca in the middle of the two planes of deuterons.
We computed an ensemble of structures using these protein-drug distances and previous SSNMR constraints. The structures cluster tightly with a heavy-atom root-mean-square deviation (r.m.s.d.) of 0.3 Å (Fig. 4) . The four helices are kinked at Gly 34, with the helical axis tilted by 30u for the N-terminal segment and 19u for the C-terminal segment, consistent with 15 N SSNMR orientational constraints 20 . The narrowest points of the pore lie at the N-terminal Val 27 and C-terminal His 37/Trp 41, which are responsible for pH sensing and proton conduction 21 . Amantadine fits snugly into the N-terminal lumen, surrounded by residues whose mutation confers resistance 9 . The surrounding backbone amides and Ser 31 hydroxyl group engage in intra-helical hydrogen bonding, imparting a hydrophobic character to the site. The luminal binding indicates that M2 inhibition is by physical occlusion, interrupting water-wires and perturbing the protonation equilibrium of His 37 (ref. 22) . The N-terminal location is consistent with the fact that Amt inhibits only when added to M2-expressing cells from the outward-facing N-terminal side 9 . Moreover, the Val 27 vestibule is too small to permit drug dissociation without a 1-2 Å radial expansion, consistent with the very slow association and dissociation of the drug compared to a diffusion-controlled process 9 . Finally, the drug is most likely oriented with the adamantane packed against the hydrophobic Val 27 side chains and the polar amine towards the cavity near His 37 residues, whose pK a are affected by Amt binding 22 .
The present SSNMR structure has significant differences from structures of the Amt-M2 complex proposed previously 2, 3 . Although the drug location is very similar to that of the low-pH crystal structure, the shape of the binding site differs dramatically (3.4-Å Ca r.m.s.d. between the structures). In the crystal structure, the helices splay far apart near the C terminus ( Fig. 5b) , to minimize electrostatic repulsions among the protonated His 37. In the high-pH SSNMR structure, the helices close off the bottom of the site, fully sequestering the drug and explaining the improved affinity at higher pH (Fig. 5a ). The backbone of the SSNMR structure is more similar to the high-pH solution NMR structure, with comparable distances involving Val 27 Cc1, Ser 31 Ca and Gly 34 Ca ( Supplementary Fig. 5 ). Thus, the drug may have been present in the lumen in the solution NMR sample but not observable without isotopic labelling. Alternatively it might have been truly absent from the lumen due to reduced affinity to the micelle-bound and structurally plastic protein [23] [24] [25] . The current highresolution structure also revises an earlier SSNMR chemical-shiftconstrained M2 model, where the lack of protein-drug distances resulted in a large N-terminal vestibule, which would yield a highly solvent-accessible low-affinity drug ( Supplementary Fig. 6-7) .
What is the significance of the peripheral site? Since it is occupied only at drug/lipid or drug/detergent ratios above 7 mol%, the proteindrug interactions at this site must be weak, and largely a consequence of the high local concentration and preference of the drug for the membrane-water interface 16 . The peripheral site may in some way be related to the partial inhibition of M2 by polyamines in the absence of sodium ions 26 .
Since amantadine undergoes significant motion in the N-terminal lumen, its structure appears to be not fully optimized to fit the M2 channel. Thus, other drugs may be designed to access the most conserved regions of the pore and evade drug resistance. Indeed, a potent and structurally distinct class of inhibitors has been recently reported that binds the same site 27 . Solid-state NMR spectroscopy, especially the multi-deuteron 13 C-2 H distance strategy, opens a new avenue for structure elucidation of drug-complexed membrane proteins in lipid bilayers, yielding distances with longer range and higher accuracy than NOE measurements in solution. S31Cα Lipid Cγ 
